Non-competitive immunochemiluminometric assay for cardiotrophin-I detects elevated plasma levels in human heart failure
暂无分享,去创建一个
Leong L. Ng | Russell J. O'brien | Bettina Demme | S Jennings | L. Ng | R. O'brien | S. Jennings | Bettina Demme
[1] S. Sasayama,et al. Augmented expression of cardiotrophin-1 and its receptor component, gp130, in both left and right ventricles after myocardial infarction in the rat. , 2000, Journal of molecular and cellular cardiology.
[2] G. Sagnella. Measurement and significance of circulating natriuretic peptides in cardiovascular disease. , 1998, Clinical science.
[3] N. Kennedy,et al. Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction. , 1996, The American journal of cardiology.
[4] M. Redfield,et al. Augmented cardiac cardiotrophin-1 in experimental congestive heart failure. , 2000, Circulation.
[5] B. Brar,et al. Cardiotrophin-1 induces heat shock protein accumulation in cultured cardiac cells and protects them from stressful stimuli. , 1998, Journal of molecular and cellular cardiology.
[6] R. T. Lie,et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. , 1996, Circulation.
[7] R. A. Hunt,et al. Cardiotrophin-1 increases angiotensinogen mRNA in rat cardiac myocytes through STAT3 : an autocrine loop for hypertrophy. , 2000, Hypertension.
[8] R. Brown,et al. Immunoassays using acridinium esters. , 1986, Methods in enzymology.
[9] W. Wood,et al. Cardiotrophin-1 , 1995, The Journal of Biological Chemistry.
[10] I. Kishimoto,et al. The heart is a source of circulating cardiotrophin-1 in humans. , 2000, Biochemical and biophysical research communications.
[11] M. Galiñanes,et al. Cardiotrophin-1 protects the human myocardium from ischemic injury. Comparison with the first and second window of protection by ischemic preconditioning. , 2000, Cardiovascular Research.
[12] D. Yellon,et al. Cardiotrophin-1 can protect cardiac myocytes from injury when added both prior to simulated ischaemia and at reoxygenation. , 2001, Cardiovascular research.
[13] J. Heath,et al. Cardiotrophin-1 Activates a Distinct Form of Cardiac Muscle Cell Hypertrophy , 1996, The Journal of Biological Chemistry.
[14] J. Davies,et al. An immunoluminometric assay for cardiotrophin-1: a newly identified cytokine is present in normal human plasma and is increased in heart failure. , 1999, Biochemical and biophysical research communications.
[15] K. Chien,et al. Cardiotrophin 1 (CT-1) Inhibition of Cardiac Myocyte Apoptosis via a Mitogen-activated Protein Kinase-dependent Pathway , 1997, The Journal of Biological Chemistry.